Prevalence and risk factors of gastroesophageal reflux symptoms in a Chinese retiree cohort

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Chen, Tiantian ^a,b   Lu, Ming ^a,b,c,d   Wang, Xiaofeng ^c,d   Yang, Yajun ^c,d   Zhang, Juan ^d   Jin, Li ^c,d   Ye, Weimin ^d,e  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d China Medical City Institute of Health Sciences   (China)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Abdominal obesity; Body mass index; Gastroesophageal reflux symptoms; Obesity; Retired population

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; PENSIONER; PEPTIC ULCER; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TEA; WAIST CIRCUMFERENCE; WAIST HIP RATIO; CHINA; LARYNGOPHARYNGEAL REFLUX; MIDDLE AGED; ODDS RATIO; RETIREMENT; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHINA; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LARYNGOPHARYNGEAL REFLUX; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PEPTIC ULCER; PREVALENCE; RETIREMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84868678995     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-161     Document Type: Article

References (32)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710-717. 10.1136/gut.2004.051821, 1774487, 15831922.
2. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000, 15:230-238. 10.1046/j.1440-1746.2000.02148.x, 10764021.
3. Lim LG, Ho KY. Gastroesophageal reflux disease at the turn of millennium. World J Gastroenterol 2003, 9:2135-2136.
4. Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol 2004, 19(Suppl 3):S22-S25.
5. Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004, 20(Suppl 8):5-8.
6. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003, 290:66-72. 10.1001/jama.290.1.66, 12837713.
7. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
8. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006, 354:2340-2348. 10.1056/NEJMoa054391, 2782772, 16738270.
9. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007, 56:756-762. 10.1136/gut.2006.109413, 1954862, 17047097.
10. Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007, 132:883-889. 10.1053/j.gastro.2006.12.032, 17324403.
11. Sise A, Friedenberg FK. A comprehensive review of gastroesophageal reflux disease and obesity. Obes Rev 2008, 9:194-203. 10.1111/j.1467-789X.2007.00459.x, 18179614.
12. Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009, 58:174-181. 10.1136/gut.2008.162305, 2605570, 18936105.
13. Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, Imai T, Mori M. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007, 26:1069-1075. 10.1111/j.1365-2036.2007.03454.x, 17877514.
14. Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol 2008, 14:709-712. 10.3748/wjg.14.709, 2683996, 18205259.
15. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000, 61:6-13. 10.1159/000007730, 10671769.
16. He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, Yin P, Kang X, Fang J, Hao Y, et al. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematic investigation of gastrointestinal diseases in China. BMC Gastroenterol 2010, 10:94. 10.1186/1471-230X-10-94, 2933714, 20707933.
17. Wang X, Lu M, Qian J, Yang Y, Li S, Lu D, Yu S, Meng W, Ye W, Jin L. Rationales, design and recruitment of the Taizhou longitudinal study. BMC Public Health 2009, 9:223. 10.1186/1471-2458-9-223, 2715397, 19589173.
18. Chinese Gastroesophageal Reflux Disease Study Group The value of reflux diagnostic questionnaires in the diagnosis of gastroesophageal reflux disease. Chin J Dig 2003, 23:651-654. in Chinese, Chinese Gastroesophageal Reflux Disease Study Group.
19. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001, 96:52-57. 10.1111/j.1572-0241.2001.03451.x, 11197287.
20. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990, 335:205-208. 10.1016/0140-6736(90)90287-F, 1967675.
21. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 1998, 7:75-83.
22. Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:5-10.
23. Mizyed I, Fass SS, Fass R. Review article: gastro-oesophageal reflux disease and psychological comorbidity. Aliment Pharmacol Ther 2009, 29:351-358. 10.1111/j.1365-2036.2008.03883.x, 19035971.
24. Wang JH, Luo JY, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol 2004, 10:1647-1651.
25. Lee SD, Keum B, Chun HJ, Bak YT. Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. J Neurogastroenterol Motil 2011, 17:274-278. 10.5056/jnm.2011.17.3.274, 3155063, 21860819.
26. Song HJ, Shim KN, Yoon SJ, Kim SE, Oh HJ, Ryu KH, Ha CY, Yeom HJ, Song JH, Jung SA, et al. The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome. J Korean Med Sci 2009, 24:197-202. 10.3346/jkms.2009.24.2.197, 2672116, 19399258.
27. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008, 57:1360-1365. 10.1136/gut.2007.147090, 18441006.
28. Cholongitas E, Pipili C, Dasenaki M. Gastro-oesophageal reflux disease and irritable bowel syndrome significantly associated with metabolic syndrome. Scand J Gastroenterol 2008, 43:1405-1406. 10.1080/00365520802308029, 18752148.
29. Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, Bittolo-Bon G. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes. Metabolism 2003, 52:616-619. 10.1053/meta.2003.50102, 12759893.
30. Tsukada K, Katoh H, Miyazaki T, Fukuchi M, Kuwano H, Kimura H, Fukai Y, Inose T, Motojima T, Toda N, et al. Factors associated with the development of reflux esophagitis after helicobacter pylori eradication. Dig Dis Sci 2006, 51:539-542. 10.1007/s10620-006-3167-2, 16614964.
31. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999, 142:207-210. 10.1016/S0021-9150(98)00194-4, 9920523.
32. Hongo M, Traube M, McAllister RG, McCallum RW. Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology 1984, 86:8-12.